We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+19.58%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$521M
AUM Growth
+$123M
(+31%)
Cap. Flow
+$74M
Cap. Flow
% of AUM
14.2%
Top 10 Holdings %
Top 10 Hldgs %
42.06%
Holding
160
New
57
Increased
37
Reduced
27
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$11.3M |
| 2 |
Amazon
AMZN
|
+$11.3M |
| 3 |
EVA
Enviva Inc.
EVA
|
+$10.5M |
| 4 |
Medifast
MED
|
+$10.1M |
| 5 |
CTLP
Cantaloupe
CTLP
|
+$8.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$13.6M |
| 2 |
CVS Health
CVS
|
+$12.8M |
| 3 |
Sunrun
RUN
|
+$11M |
| 4 |
Adobe
ADBE
|
+$10.1M |
| 5 |
ServiceNow
NOW
|
+$8.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.67% |
| 2 | Industrials | 16.23% |
| 3 | Healthcare | 15.24% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Consumer Staples | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WAAS
26
DELISTED
AquaVenture Holdings Limited
WAAS
| $6.17M | 1.18% |
319,000
-261,291
| -45% | -$5.41M |
|
|
27
Adobe
ADBE
$99B
| $6M | 1.15% |
22,500
-40,000
| -64% | -$10.1M |
|
28
Advanced Micro Devices
AMD
$741B
| $5.95M | 1.14% |
233,000
+178,000
| +324% | +$4.04M |
|
29
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $5.88M | 1.13% |
65,000
+60,500
| +1,344% | +$5.15M |
|
|
PGNX
30
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $5.82M | 1.12% |
1,255,000
+727,900
| +138% | +$3.29M |
|
|
AMRS
31
DELISTED
Amyris Inc.
AMRS
| $5.71M | 1.1% |
2,732,500
+1,343,000
| +97% | +$5.3M |
|
32
Bristol-Myers Squibb
BMY
$130B
| $5.06M | 0.97% |
+106,000
| New | +$5.28M |
|
33
Yext
YEXT
$564M
| $4.6M | 0.88% |
+210,550
| New | +$3.82M |
|
|
COUP
34
DELISTED
Coupa Software Incorporated
COUP
| $4.32M | 0.83% |
47,500
+37,500
| +375% | +$3.21M |
|
|
VRNT
35
DELISTED
Verint Systems
VRNT
| $4.19M | 0.8% |
+137,410
| New | +$3.49M |
|
36
Okta
OKTA
$23.7B
| $4.14M | 0.79% |
50,000
-35,000
| -41% | -$2.77M |
|
|
STMP
37
CALL
DELISTED
Stamps.com, Inc.
STMP
| $4.07M | 0.78% |
+50,000
| New | +$7.03M |
|
|
MOBL
38
DELISTED
MobileIron, Inc.
MOBL
| $3.25M | 0.62% |
+595,000
| New | +$2.93M |
|
39
Golar LNG
GLNG
$4.95B
| $3.11M | 0.6% |
147,500
+47,500
| +48% | +$1.05M |
|
|
ZUO
40
DELISTED
Zuora, Inc.
ZUO
| $3M | 0.58% |
150,000
+105,000
| +233% | +$2.27M |
|
|
AIOT
41
PowerFleet Inc
AIOT
$525M
| $2.96M | 0.57% |
499,088
+10,000
| +2% | +$62.5K |
|
42
Champion Homes
SKY
$4.58B
| $2.8M | 0.54% |
147,500
-67,500
| -31% | -$1.24M |
|
43
Pan American Silver
PAAS
$18.2B
| $2.65M | 0.51% |
+200,000
| New | +$2.8M |
|
|
CTLP
44
CALL
DELISTED
Cantaloupe
CTLP
| $2.49M | 0.48% |
+600,000
| New | +$2.69M |
|
45
UnitedHealth
UNH
$389B
| $2.47M | 0.47% |
10,000
+4,000
| +67% | +$1.02M |
|
|
BFYT
46
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $2.41M | 0.46% |
+90,000
| New | +$3.19M |
|
|
TTOO
47
DELISTED
T2 Biosystems, Inc
TTOO
| $2.17M | 0.42% |
165
+23
| +16% | +$391K |
|
|
RDNW
48
RideNow Group
RDNW
$251M
| $1.67M | 0.32% |
+16,935
| New | +$1.91M |
|
49
CALL
Deutsche Bank
DB
$67.6B
| $1.62M | 0.31% |
200,000
| – | – |
|
|
AMRS
50
CALL
DELISTED
Amyris Inc.
AMRS
| $1.48M | 0.28% |
705,700
+700,000
| +12,281% | +$2.76M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Ardsley Advisory Partners held 160 positions worth $521M, up 31% from $398M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ardsley Advisory Partners deployed $74M of net new capital in Q1 2019, opening 57 new positions and adding to 37 existing holdings. Its largest new stake was Medifast: 80,000 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Sunrun, an estimated $11M trimmed.
- Ardsley Advisory Partners's largest Q1 2019 buy was Medifast: 80,000 shares worth $10.2M.
- Ardsley Advisory Partners added most to Celgene Corp in Q1 2019, an estimated $11.3M increase.
- Ardsley Advisory Partners's biggest Q1 2019 reduction was Sunrun, cutting an estimated $11M.
- Ardsley Advisory Partners fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $13.6M.
- Ardsley Advisory Partners's ten largest holdings make up 42% of its $521M portfolio in Q1 2019.
- Ardsley Advisory Partners opened 57 new positions and closed 29 in Q1 2019.
- Ardsley Advisory Partners's portfolio value rose 31% quarter-over-quarter to $521M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.